Summary of Components of Preliminary Purchase Price Allocation for Acquisition of Vilebrequin (Detail) In Thousands, unless otherwise specified			1 Months Ended		3 Months Ended	0 Months Ended
	Jan. 31, 2014 USD ($)	Jan. 31, 2013 USD ($)	Aug. 07, 2012 Vilebrequin USD ($)	Aug. 07, 2012 Vilebrequin EUR (€)	Jul. 31, 2013 Vilebrequin USD ($)	Nov. 04, 2013 G.H. Bass USD ($)
Purchase price:
Cash paid			$ 87,600	€ 70,500	$ 87,573	$ 49,236
Notes issued			18,600	15,000	18,633
Fair value of contingent consideration	5,550	5,787	5,400		5,452
Total consideration paid by the company in business acquisition			111,700		111,658	49,236
Allocation:
Current assets					25,793	42,967
Property, plant and equipment					5,724	2,788
Identifiable intangible assets					68,847	2,490
Other non-current assets, net					15,274	975
Assumed liabilities					(12,938)	(700)
Deferred income taxes					(17,820)
Goodwill	55,604	60,396			26,778	716
Total consideration paid by the Company in business acquisition			$ 111,700		$ 111,658	$ 49,236